Morgan Stanley Institutional Investment Advisors’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$166M Buy
1,038,804
+17
+0% +$2.61K 16% 3
2025
Q4
$142M Buy
1,038,787
+289,566
+39% +$37.4M 15.05% 3
2025
Q3
$91M Sell
749,221
-2,944
-0.4% -$318K 10.94% 3
2025
Q2
$80.5M Sell
752,165
-4,432
-0.6% -$443K 9.96% 3
2025
Q1
$70.2M Sell
756,597
-15,513
-2% -$1.5M 16.47% 2
2024
Q4
$83M Sell
772,110
-8,327
-1% -$1.01M 19.01% 2
2024
Q3
$98.2M Buy
+780,437
New +$98.1M 22.05% 2

Other funds holding NHC

Morgan Stanley Institutional Investment Advisors's NHC Position: Q1 2026 in Review

Morgan Stanley Institutional Investment Advisors increased its National Healthcare (NHC) stake by 0% in Q1 2026, buying an estimated $2.61K and bringing the position to 1,038,804 shares worth $166M. The position accounts for 16% of the portfolio, ranked #3.

Morgan Stanley Institutional Investment Advisors first reported a position in NHC in Q3 2024 and has held it in 7 quarters since. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.

  • Morgan Stanley Institutional Investment Advisors held 1,038,804 shares of National Healthcare worth $166M as of Q1 2026.
  • Morgan Stanley Institutional Investment Advisors bought 17 National Healthcare shares in Q1 2026, an estimated $2.61K.
  • National Healthcare made up 16% of Morgan Stanley Institutional Investment Advisors's portfolio in Q1 2026, its #3 holding.
  • Morgan Stanley Institutional Investment Advisors first reported a position in National Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.

Based on Morgan Stanley Institutional Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.